The Babraham Institute undertakes world-leading research into understanding the biology of how our bodies work, including what changes as we age and during disease. Our research is split into three programmes: Epigenetics, Signalling, and Lymphocyte Signalling, supported by strategic programme grants from the Biotechnology and Biological Sciences Research Council (BBSRC) and additional funding from research councils, the EU and charities.

We maximise the impact of our research through Knowledge Exchange, Commercialisation and Public Engagement activities. We do this by collaborating with other academics, policy makers, charities, schools, the general public and industry, including companies on the Babraham Research Campus. Commercialisation is achieved in collaboration with the Institute’s wholly-owned trading arm, Babraham Institute Enterprise Limited.



New group leader joins the Epigenetics research programme

Institute welcomes Dr Maria Christophorou

Research focuses on control of epigenetic regulators


EU grant success to harness the immune system to treat brain damage

Research identifies potential treatment for brain injury and inflammation

Funding awarded to Prof Adrian Liston will be used to advance the approach ready for clinical trials


Single-cell analysis of the earliest cell fate decisions in development

Research published in Nature

Multi-omics analysis of the process establishing the mammalian body plan


Institute joins the Technician Commitment

Valuing technical expertise

Commitment will engage, increase recognition and evaluate career support

Access our Science Services

Biological Support Unit
Biological Chemistry
Flow Cytometry
Mass Spectrometry
Gene Targeting

The Bioinformatics group provides an interface between the computational infrastructure of the institute and the biology performed within the research groups


The Imaging Facility provides supported access to advanced fluorescence imaging technologies and image analysis solutions.


The Facility plays a crucial role in all the Institute’s research programmes and is also available to external users on a fee-for-service basis

Biological Support Unit

Our state-of-the-art Biological Support Unit (BSU) provides housing and care for pathogen-free rodents. It supports research across the Institute as well as providing ser


We have established methods to analyse neutral lipids, phospholipids and sphingolipids using a Shimadzu IT-TOF mass spectrometer coupled to a Prominence HPLC system

Biological Chemistry

Biological chemistry is the interface between chemistry and biology, requiring both synthetic organic chemistry skills and a knowledge of biochemistry

Flow Cytometry

The Babraham Institute Flow Cytometry Core Facility offers high quality service and state-of-the-art instrumentation to members of Babraham Institute and external users.

Mass Spectrometry

The Mass Spectrometry Facility is housed in a purpose-built laboratory in a new building in the centre of the campus

Gene Targeting

Providing a complete service to generate genetically altered mouse strains for Babraham Institute research groups and external companies


Babraham Institute Seminar Series

Featuring Institute group leaders, students and invited guests


Schools' Day - 26th February 2020

Hands-on science for students and teachers

Key visitor pages

Members of the public may wish to look at the following pages to find out how the Babraham Institute works with and for society:

The following pages may be of particular interest to those in the Academic community:

Members of the media and journalists may wish to visit the following sections for further details about our work:

Follicular Regulatory T Cells Can Access the Germinal Center Independently of CXCR5.

Vanderleyden I, Fra-Bido SC, Innocentin S,

Cell reports
30 3: 21 Jan 2020

DOI: 10.1016/j.celrep.2019.12.076

PMID: 31968240

Using Genome-Scale Metabolic Networks for Analysis, Visualization, and Integration of Targeted Metabolomics Data.

Hattwell JPN, Hastings J, Casanueva O,

Methods in molecular biology (Clifton, N.J.)
2104 1: 2020

DOI: 10.1007/978-1-0716-0239-3_18

PMID: 31953826

Temporal inhibition of autophagy reveals segmental reversal of ageing with increased cancer risk.

Cassidy LD, Young ARJ, Young CNJ,

Nature communications
11 1: 16 Jan 2020

DOI: 10.1038/s41467-019-14187-x

PMID: 31949142

MYC regulates fatty acid metabolism through a multigenic program in claudin-low triple negative breast cancer.

Casciano JC, Perry C, Cohen-Nowak AJ,

British journal of cancer
1 1: 16 Jan 2020

DOI: 10.1038/s41416-019-0711-3

PMID: 31942031